Statements Of Consolidated Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Flows From Operating Activities:
Net income (loss)	$ (20,451,080)	$ (3,094,306)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Stock-based compensation expense	736,186	27,707
Amortization of intangible assets	128,256	0
Loss on investments	7,070,841	0
Depreciation	779	0
Amortization of debt discount	4,434,751	2,072,000
Acquisition consideration paid in common stock	5,800,000	0
Changes in operating assets and liabilities
(Increase)/decrease in prepaid expenses	(1,869,283)	(134,689)
Accrued interest	27,630	68,052
Mortgages payable	(500,435)	0
Accounts payable related party	145,291	9,000
Accrued expense related party	456,356	0
Accounts payable and accrued expense	225,937	111,100
Net cash provided by (used for) operating activities	(3,794,771)	(941,136)
Cash Flows From Investing Activities:
Purchase of fixed assets	(4,774)	0
Cash paid for the acquisition of AMS	0	(726,746)
Capitalized mortgage interest and changes in construction in progress	(42,163)	0
Net cash provided by (used for) investing activities	(46,937)	(726,746)
Cash Flows From Financing Activities:
Proceeds from the sale of convertible notes	1,550,000	2,072,000
Proceeds from the sale of notes payable	1,050,000	0
Purchase of treasury shares	(98,955)	0
Proceeds from related party loans	290,400	0
Proceeds from the sale of preferred stock	475,000	60,000
Net cash provided by (used for) financing activities	3,266,445	2,132,000
Effect of exchange rates on cash and cash equivalents	112,692	0
Net Increase (Decrease) In Cash	(575,263)	464,118
Cash At The Beginning Of The Period	464,118	0
Cash At The End Of The Period	1,547	464,118
Supplemental disclosure of cash flow information:
Cash paid for interest	66,016	0
Cash paid for income taxes	0	0
Supplemental disclosure of non-cash investing and financing activities:
Common stock issued related to the acquisition of AMS	0	1,612,600
Debt issued related to the acquisition of AMS	0	6,632,917
Other accrued consideration related to the acquisition of AMS	0	527,010
Common stock issued related to investment in Great Northern Cannabis	11,264,438	0
Common stock issued to convert convertible notes and accrued interest into equity	$ 2,202,213	$ 0